Super-stereotypy II: Enhancement of a complex movement sequence by intraventricular dopamine D1 agonists

Synapse

Volumn 37, Issue 3, 2000, Pages 205-215

  Berridge, Kent C ^a   Aldridge, J Wayne ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ACTH; Basal ganglia; D1 receptor; D2 receptor; Dopamine; Fixed action pattern; Grooming; Movement sequence; Neostriatum; Nigrostriatal dopamine; Parkinson's disease; Peptide; Quinpirole; SKF 38393; SKF 82958; Stereotyped movement; Striatum; Tourette's Syndrome

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; QUINPIROLE; TETRACOSACTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; GROOMING; HISTOPATHOLOGY; MALE; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BENZAZEPINES; CATHETERIZATION; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GROOMING; INJECTIONS, INTRAVENTRICULAR; INSTINCT; MALE; MICROINJECTIONS; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR;

EID: 0034284889     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20000901)37:3<205::AID-SYN4>3.0.CO;2-A     Document Type: Article

References (71)

1. Aldridge JW, Berridge KC. 1998. Coding of serial order by neostriatal neurons: A "natural action" approach to movement sequence. J Neurosci 18:2777-2787.
2. Aldridge JW, Berridge KC, Herman M, Zimmer L. 1993. Neuronal coding of serial order: Syntax of grooming in the neostriatum. Psychol Sci 4:391-395.
3. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui LC. 1996. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am J Med Genet 67:301-305.
4. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui LC. 1997. Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome. Am J Med Genet 74:58-61.
5. Berns GS, Sejnowski TJ. 1998. A computational model of how the basal ganglia produce sequences. J Cog Neurosci 10:108-121.
6. Berridge KC. 1989. Substantia nigra 6-OHDA lesions mimic striatopallidal disruption of syntactic grooming chains: A neural systems analysis of sequence control. Psychobiology 17:377-385.
7. Berridge KC. 1990. Comparative fine structure of action: Rules of form and sequence in the grooming patterns of six rodent species. Behavior 113:21-56.
8. Berridge KC, Fentress JC. 1987. Disruption of natural grooming chains after striatopallidal lesions. Psychobiology 15:336-342.
9. Berridge KC, Whishaw IQ. 1992. Cortex, striatum and cerebellum: Control of serial order in a grooming sequence. Exp Brain Res 90:275-290.
10. Berridge KC, Fentress JC, Parr H. 1987. Natural syntax rules control action sequence of rats. Behav Brain Res 23:59-68.
11. Bolivar VJ, Danilchuk W, Fentress JC. 1996. Separation of activation and pattern in grooming development of weaver mice. Behav Brain Res 75:49-58.
12. Bordi F, Meller E. 1989. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats. Brain Res 504:276-283.
13. Braun A, Mouradian MM, Mohr E, Fabbrini G, Chase TN. 1989. Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders. Journal of Neurology, Neurosurg Psychiatry 52:631-635.
14. Bursten SN, Berridge KC, Owings DH. (in press). Evolution of a mammalian display from a phylogenetically ancient grooming pattern. J Comp Psychol (in press).
15. Cardoso FE, Jankovic J. 1993. Cocaine-related movement disorders. Move Disord 8:175-178.
16. Catalano M, Sciuto G, Di Bella D, Novelli E, Nobile M, Bellodi L. 1994. Lack of association between obsessive-compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet 54:253-255.
17. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW. 1991. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266:1793-1800.
18. Cools AR, Wiegant VM, Gispen WH. 1978. Distinct dopaminergic systems in ACTH-induced grooming. Eur J Pharmacol 50:265-268.
19. Cools AR, Spruijt BM, Ellenbroek BA. 1988. Role of central dopamine in ACTH-induced grooming behavior in rats. Ann NY Acad Sci 525:338-349.
20. Coscia EM, Fentress JC. 1993. Neurological dysfunction expressed in the grooming behavior of developing Weaver mutant mice. Behav Genet 23:533-541.
21. Cromwell HC, Berridge KC. 1996. Implementation of action sequences by a neostriatal site: A lesion mapping study of grooming syntax. J Neurosci 16:3444-3458.
22. Cromwell HC, Berridge KC, Drago J, Levine MS. 1998. Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 10:2426-2432.
23. Delfs JM, Kelley AE. 1990. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39:59-67.
24. Deveney AM, Waddington JL. 1995. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116:2120-2126.
25. Deveney AM, Waddington JL. 1997. Psychopharmacological distinction between novel full-efficacy "D-1-like" dopamine receptor agonists. Pharmacol Biochem Behav 58:551-558.
26. Dickson PR, Lang CG, Hinton SC, Kelley AE. 1994. Oral stereotypy induced by amphetamine microinjection into striatum: An anatomical mapping study. Neuroscience 61:81-91.
27. Downes RP, Waddington JL. 1993. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase. Eur J Pharmacol 234:135-136.
28. Dunn AJ. 1988. Studies on the neurochemical mechanisms and significance of ACTH-induced grooming. Ann NY Acad Sci 525:150-168.
29. Dunn AJ, Berridge CW. 1990. Physiological and behavioral-responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses. Brain Res Rev 15:71-100.
30. Dunn AJ, Berridge CW, Lai YI, Yachabach TL. 1987. CRF-induced excessive grooming behavior in rats and mice. Peptides 8:841-844.
31. Eilam D, Talangbayan H, Canaran G, Szechtman H. 1992. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology 106:447-454.
32. Fletcher GH, Starr MS. 1987. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience 20:589-597.
33. Florijn WJ, Holtmaat AJ, de Lang H, Spierenburg H, Gispen WH, Versteeg DH. 1993. Peptide-induced grooming behavior and caudate nucleus dopamine release. Brain Res 625:169-172.
34. Flynn FW. 1991. Effects of 4th ventricle bombesin injection on meal-related parameters and grooming behavior. Peptides 12:761-765.
35. Gelernter J, Pakstis AJ, Pauls DL, Kurlan R, Gancher ST, Civelli O, Grandy D, Kidd KK. 1990. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. Archives of General Psychiatry 47:1073-1077.
36. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R. 1994. D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. Arch Neurol 51:397-400.
37. Gispen WH, Isaacson RL. 1981. ACTH-induced excessive grooming in the rat. Pharmacol Therapeut 12:209-246.
38. Gispen WH, Wiegant VM, Greven HM, de Wied D. 1975. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies. Life Sci 17:645-652.
39. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. 1990. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiat 51(Suppl):36-43 (discussion 55-58).
40. Guild AL, Dunn AJ. 1982. Dopamine involvement in ACTH-induced grooming behavior. Pharmacol Biochem Behav 17:31-36.
41. Hartgraves SL, Randall PK. 1986. Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion. Psychopharmacology 90:358-363.
42. Hollander E, Liebowitz MR, DeCaria CM. 1989. Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders. Psychiat Dev 7:267-296.
43. Isaacson RL, Hannigan JH Jr, Brakkee JH, Gispen WH. 1983. The time course of excessive grooming after neuropeptide administration. Brain Res Bull 11:289-293.
44. Isaacson RL, Thomas J. 1986. Character of (D-Phe-7) ACTH4-10-induced excessive grooming. Exp Neurol 93:657-661.
45. Kulkosky PJ, Foderaro MA, Glazner GW, Niichel VI, Schnur P. 1988. Bombesin-induced grooming in the golden hamster. Behav Brain Res 29:173-177.
46. McDougle CJ. 1997. Update on pharmacologic management of OCD: agents and augmentation. J Clin Psychiat 58(Suppl 12):11-17.
47. McDougle CJ, Goodman WK, Price LH. 1993. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry 26(Suppl 1): 24-29.
48. Moody TW, Merali Z, Crawley JN. 1988. The effects of anxiolytics and other agents on rat grooming behavior. Ann NY Acad Sci 525:281-290.
49. Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB. 1996. Conformational analysis of D1 dopamine receptor agonists: Pharmacophore assessment and receptor mapping. J Med Chem 39:285-296.
50. Neisewander JL, Ong A, McGonigle P. 1995. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse 19:134-143.
51. Page SJ, Terry P. 1997. Conditioned grooming induced by the dopamine D1-like receptor agonist SKF 38393 in rats. Pharmacol Biochem Behav 57:829-833.
52. Petter T, Richter MA, Sandor P. 1998. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics. J Clin Psychiat 59:456-459.
53. Phillips GD, Howes SR, Whitelaw RB, Robbins TW, Everitt BJ. 1995. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence. Psychopharmacology 117:82-90.
54. Piggins H, Merali Z. 1992. On the ontogenetic and sequential characteristics of bombesin-induced grooming in the infant rat. Dev Brain Res 67:247-256.
55. Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A. 1998. Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharm 21:97-100.
56. Ranaldi R, Beninger RJ. 1994. The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward. Brain Res 651:283-292.
57. Rapoport JL. 1994. Le "spectre obsessionnel-compulsif": Un concept utile? Encephale 20 Spec No 4:677-680.
58. Rapoport JL, Wise SP. 1988. Obsessive-compulsive disorder: Evidence for basal ganglia dysfunction. Psychopharmacol Bull 24:380-384.
59. Ridley RM. 1994. The psychology of perseverative and stereotyped behaviour. Prog Neurobiol 44:221-231.
60. Ruskin DN, Rawji SS, Walters JR. 1998. Effects of full D-1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: Tests for D-1 receptor selectivity and comparisons to the partial agonist SKF 38393. J Pharmacol Exp Ther 286:272-281.
61. Spruijt BM, Cools AR, Ellenbroek BA, Gispen WH. 1986. Dopaminergic modulation of ACTH-induced grooming. Eur J Pharmacol 120: 249-256.
62. Starr BS, Starr MS. 1986. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology 25:455-463.
63. Toates F. 1990. Obsessional thoughts and behaviour. London: Thorsons (Harper Collins).
64. Trampus M, Ferri N, Adami M, Ongini E. 1993. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 235:83-87.
65. Van Erp AM, Kruk MR, De Kloet ER. 1993. Induction of grooming in resting rats by intracerebroventricular oxytocin but not by adrenocorticotropic hormone-(1-24) and alpha-melanocyte-stimulating hormone. Eur J Pharmacol 232:217-221.
66. Van Wimersma Greidanus TB, Maigret C, Torn M, Ronner E, Van der Kracht S, Van der Wee NJ, Versteeg DH. 1989. Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming. Eur J Pharmacol 173:227-231.
67. Wachtel SR, Hu XT, Galloway MP, White FJ. 1989. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse 4:327-346.
68. Wachtel SR, Brooderson RJ, White FJ. 1992. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology 109:41-48.
69. White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. 1988. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol Biochem Behav 30:189-193.
70. Wirtshafter D, Krebs JC. 1997. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos expression in the lateral habenula. Brain Res 750:245-250.
71. Zhang SP, Zhou LW, Weiss B. 1994. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. J Pharmacol Exp Ther 271:1462-1470.